SIRACUSA, MASSIMILIANO
 Distribuzione geografica
Continente #
EU - Europa 2.077
NA - Nord America 1.732
AS - Asia 864
SA - Sud America 258
Continente sconosciuto - Info sul continente non disponibili 95
AF - Africa 35
OC - Oceania 2
Totale 5.063
Nazione #
US - Stati Uniti d'America 1.688
RU - Federazione Russa 1.052
SG - Singapore 322
CN - Cina 266
IE - Irlanda 218
BR - Brasile 215
IT - Italia 201
SE - Svezia 199
DE - Germania 112
HK - Hong Kong 95
FR - Francia 70
FI - Finlandia 54
VN - Vietnam 52
GB - Regno Unito 43
IN - India 42
PL - Polonia 36
UA - Ucraina 22
BD - Bangladesh 20
CA - Canada 20
AT - Austria 14
CO - Colombia 11
NL - Olanda 11
ZA - Sudafrica 11
AR - Argentina 10
BE - Belgio 10
IQ - Iraq 8
JP - Giappone 8
MX - Messico 8
CI - Costa d'Avorio 7
CZ - Repubblica Ceca 7
ES - Italia 7
ID - Indonesia 6
PK - Pakistan 6
BO - Bolivia 5
CL - Cile 5
MA - Marocco 5
TR - Turchia 5
EC - Ecuador 4
JM - Giamaica 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DZ - Algeria 3
IR - Iran 3
LT - Lituania 3
MK - Macedonia 3
MY - Malesia 3
PS - Palestinian Territory 3
PY - Paraguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
XK - ???statistics.table.value.countryCode.XK??? 3
CH - Svizzera 2
CR - Costa Rica 2
EU - Europa 2
GR - Grecia 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
SA - Arabia Saudita 2
VC - Saint Vincent e Grenadine 2
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
KI - Kiribati 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.973
Città #
Ashburn 287
Moscow 264
Dublin 218
Chandler 213
Singapore 194
Dallas 183
Nyköping 110
Hong Kong 95
Beijing 91
San Jose 82
Messina 60
The Dalles 55
Council Bluffs 52
Jacksonville 51
Munich 40
Warsaw 34
Lauterbourg 33
Los Angeles 30
Dearborn 29
Princeton 28
Medford 25
Des Moines 23
Turku 23
New York 22
Bremen 21
Hyderabad 20
Cambridge 19
Ho Chi Minh City 17
Tianjin 13
Hanoi 11
Redondo Beach 11
Santa Clara 11
São Paulo 11
Vienna 11
Brussels 10
Helsinki 10
Jinan 10
Orem 10
Boardman 9
Brooklyn 9
Frankfurt am Main 9
Atlanta 8
Bologna 8
Buffalo 8
Johannesburg 8
Lancaster 8
San Mateo 8
Shenyang 8
Tokyo 8
Abidjan 7
Belo Horizonte 7
Guangzhou 7
London 7
Montreal 7
Nuremberg 7
Pune 7
Washington 7
Bexley 6
Chicago 6
Dong Ket 6
Hangzhou 6
Hebei 6
Phoenix 6
Rio de Janeiro 6
Taizhou 6
Wilmington 6
Woodbridge 6
Ann Arbor 5
Brasília 5
Denver 5
Manchester 5
Medellín 5
Nanjing 5
San Francisco 5
Vittoria 5
Changsha 4
Chennai 4
Düsseldorf 4
Fuzhou 4
Malnate 4
Mazzarrone 4
Milan 4
Milazzo 4
Nanchang 4
Nürnberg 4
Rome 4
Toronto 4
Ardabil 3
Baghdad 3
Boston 3
Brno 3
Buenos Aires 3
Charlotte 3
Goiânia 3
Hillsboro 3
Houston 3
Jakarta 3
Leawood 3
Memphis 3
Mumbai 3
Totale 2.761
Nome #
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 280
CyberKnife Radiosurgery Alone or Combined with "Dose Dense" Temozolomide Administration for Recurrent Gliomas. 242
Radioterapia Stereotassica ad alte dosi mediante sistema IGRT. Puo' migliorare il controllo locale di malattia e la sopravvivenza nei pazienti con oligometastasi? 210
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 203
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 193
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 189
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 187
IMAGE-GUIDED RADIOTHERAPY (IGRT; oF THE CYBERKNIFE RADIOSURGERY FOR TREATING OPTIC AND PERIOPTIC LESIONS. 184
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 183
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 182
HER2 analysis in sporadic thyroid cancer of follicular cell origin 179
Evoluzione tecnologica nel trattamento radiochirurgico delle metastasi cerebrali. Esperienza decennale del Centro di Messina. 177
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 173
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 171
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 170
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer 163
STEREOTACTIC ROBOTIC RADIOSURGERY IN THE MANAGEMENT OF PALLIATIVE RADIOSURGERY FOR BRAIN METASTASES: A RETROSPECTIVE ANALYSIS. 155
RADIOSURGERY FOR SINGLE SPINALMETASTASES COMBINING DOUBLE DOSE WITHIGRT MODALITY. PRELIMINARY EXPERIENCE 154
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 154
Radiobiological and clinical evalutation of retreatment for spinal bone metastases following different fractionation schemes 153
VALUTAZIONE COMPARATIVA SU BASE RADIOBIOLOGICA DEGLI EFFETTI DOSE-VOLUME SUL MIDOLLO SPINALE SOTTOPOSTOA REGIMI DI TRATTAMENTO RADIANTE IPOFRAZIONATI UTILIZZANDO IL MODELLO LINEARE QUADRATICO STANDARD ED ILMODELLO LINEARE QUADRATICO IBRIDO 151
ESPERIENZA DEL TRATTAMENTO ADIUVANTE DEL CARCINOMA GASTRICO. STADIO DI MALATTIA E CAMPO DITRATTAMENTO 149
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 145
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario 123
Malignant thyroid nodule topography as additional risk factor for lymph-node metastases in differentiated thyroid cancer patients 114
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study 112
Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers 105
Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real Life Study 95
BRAF (V600E) mutation in isthmic malignant thyroid nodules 94
Usefulness of 123I-spect/ct to assess the response to initial therapy in differentiated thyroid cancer patients 66
Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients 56
SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives 56
Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic 35
Nodal metastasis in noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) 29
null 26
Oldie but Goldie: The Fundamental Role of Radioiodine in the Management of Thyroid Cancer 5
Totale 5.063
Categoria #
all - tutte 16.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.511


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022212 0 0 3 11 7 2 11 5 2 53 42 76
2022/2023699 55 82 36 57 59 78 12 34 264 0 17 5
2023/2024223 12 25 8 25 20 46 9 31 0 21 12 14
2024/2025759 20 14 9 35 37 34 25 109 170 66 101 139
2025/20262.417 144 153 183 160 176 446 270 335 337 126 39 48
2026/2027190 35 142 13 0 0 0 0 0 0 0 0 0
Totale 5.063